BR0111982A - Tratamento com apomorfina, de disfunção sexual induzida por droga anti depressão - Google Patents
Tratamento com apomorfina, de disfunção sexual induzida por droga anti depressãoInfo
- Publication number
- BR0111982A BR0111982A BR0111982-6A BR0111982A BR0111982A BR 0111982 A BR0111982 A BR 0111982A BR 0111982 A BR0111982 A BR 0111982A BR 0111982 A BR0111982 A BR 0111982A
- Authority
- BR
- Brazil
- Prior art keywords
- sexual dysfunction
- apomorphine
- treatment
- induced sexual
- depression drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Otolaryngology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
"TRATAMENTO COM APOMORFINA, DE DISFUNçãO SEXUAL INDUZIDA POR DROGA ANTIDEPRESSãO". é revelado um método para tratar disfunção sexual em um paciente tomando medicação antidepressora que necessita do referido tratamento compreendendo administrar uma quantidade terapeuticamente eficaz de apomorfina ou um seu sal farmaceuticamente aceitável, ao referido paciente. o método pode ser utilizado para pacientes que tomam antidepressores como antidepressores tricíclicos, inibidores de monoamina oxidase ou inibidores de reabsorção seletiva de serotonina.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24903100P | 2000-11-15 | 2000-11-15 | |
PCT/US2001/043933 WO2002039879A2 (en) | 2000-11-15 | 2001-11-14 | Treatment of anti-depression drug-induced sexual dysfunction with apomorphine |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0111982A true BR0111982A (pt) | 2003-10-28 |
Family
ID=22941748
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0111982-6A BR0111982A (pt) | 2000-11-15 | 2001-11-14 | Tratamento com apomorfina, de disfunção sexual induzida por droga anti depressão |
Country Status (18)
Country | Link |
---|---|
US (1) | US6528521B2 (pt) |
EP (1) | EP1341536A4 (pt) |
JP (1) | JP2004513899A (pt) |
KR (1) | KR20030077538A (pt) |
CN (1) | CN1486183A (pt) |
AU (1) | AU2002235129A1 (pt) |
BG (1) | BG107874A (pt) |
BR (1) | BR0111982A (pt) |
CA (1) | CA2429047A1 (pt) |
CZ (1) | CZ20031540A3 (pt) |
HU (1) | HUP0302436A3 (pt) |
IL (1) | IL155667A0 (pt) |
MX (1) | MXPA03004288A (pt) |
NO (1) | NO20032189L (pt) |
PL (1) | PL361875A1 (pt) |
SK (1) | SK7422003A3 (pt) |
WO (1) | WO2002039879A2 (pt) |
ZA (1) | ZA200303471B (pt) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6787532B2 (en) * | 2000-08-05 | 2004-09-07 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivatives |
US20060178394A1 (en) * | 2003-04-14 | 2006-08-10 | Staniforth John N | Pharmaceutical compositions comprising apomorphine for pulmonary inhalation |
US20040204439A1 (en) * | 2003-04-14 | 2004-10-14 | Staniforth John Nicholas | Composition, device, and method for treating sexual dysfunction via inhalation |
ES2426915T3 (es) | 2003-09-10 | 2013-10-25 | Brentwood Equities Ltd. | Diastereoisómeros de 4-ariloxi-3-hidroxipiperidinas |
GB0425758D0 (en) | 2004-11-23 | 2004-12-22 | Vectura Ltd | Preparation of pharmaceutical compositions |
GB0721394D0 (en) * | 2007-10-31 | 2007-12-12 | Vectura Group Plc | Compositions for trating parkinson's disease |
BR112013015204A2 (pt) | 2010-12-16 | 2019-10-01 | Arx Llc | composição farmacêutica em forma de unidade de dosagem formulada para administração sublingual e uso da referida composição |
CN104884064A (zh) | 2012-12-24 | 2015-09-02 | 纽洛佳斯特拉斯公司 | 用于治疗胃肠道病症的方法 |
CA3127926A1 (en) | 2015-04-21 | 2016-10-27 | Sunovion Pharmaceuticals Inc. | Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa |
WO2017168174A1 (en) | 2016-04-02 | 2017-10-05 | N4 Pharma Uk Limited | New pharmaceutical forms of sildenafil |
KR20200110671A (ko) * | 2018-01-18 | 2020-09-24 | 레우코스 바이오테크 에스. 엘. | 아포몰핀·팔미트산 공결정 고체 입자 결정질 형태 |
US11717495B2 (en) * | 2020-03-16 | 2023-08-08 | Vella Bioscience, Inc. | Use of cannabinoids in treating anti-depressant-induced female sexual dysfunction |
US10836757B1 (en) | 2020-04-02 | 2020-11-17 | Neurogastrx, Inc. | Polymorphic forms of metopimazine |
CN115671106B (zh) * | 2021-07-21 | 2024-03-19 | 广州新济药业科技有限公司 | ***的应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4521421A (en) * | 1983-09-26 | 1985-06-04 | Eli Lilly And Company | Treatment of sexual dysfunction |
US5756483A (en) | 1993-03-26 | 1998-05-26 | Merkus; Franciscus W. H. M. | Pharmaceutical compositions for intranasal administration of apomorphine |
DE69514794T2 (de) | 1994-04-22 | 2000-07-27 | Pentech Pharmaceuticals Inc | Sublinguale dosierungsformen enthaltend apomorphin zur verwendung bei der behandlung von erektiler dysfunktion |
US5562917A (en) | 1994-12-23 | 1996-10-08 | Pentech Pharmaceuticals, Inc. | Transdermal administration of apomorphine |
US5888534A (en) * | 1995-06-13 | 1999-03-30 | Pentech Pharmaceuticals, Inc. | Controlled release of drugs delivered by sublingual or buccal administration |
ATE211906T1 (de) | 1996-03-12 | 2002-02-15 | Alza Corp | Zusammensetzung und dosisform mit einem opioid- antagonisten |
US5897864A (en) | 1996-05-23 | 1999-04-27 | Cohen; Alan J. | Method for treating sexual dysfunction disorders with compositions containing ginkgo biloba |
JP2001504851A (ja) * | 1996-12-02 | 2001-04-10 | メルク シヤープ エンド ドーム リミテツド | 性的機能不全の治療のためのnk−1受容体拮抗薬の使用 |
US5945117A (en) | 1998-01-30 | 1999-08-31 | Pentech Pharmaceuticals, Inc. | Treatment of female sexual dysfunction |
US6399826B1 (en) * | 1999-08-11 | 2002-06-04 | Sepracor Inc. | Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain |
-
2001
- 2001-11-14 BR BR0111982-6A patent/BR0111982A/pt not_active IP Right Cessation
- 2001-11-14 WO PCT/US2001/043933 patent/WO2002039879A2/en not_active Application Discontinuation
- 2001-11-14 MX MXPA03004288A patent/MXPA03004288A/es unknown
- 2001-11-14 KR KR10-2003-7006518A patent/KR20030077538A/ko not_active Application Discontinuation
- 2001-11-14 CA CA002429047A patent/CA2429047A1/en not_active Abandoned
- 2001-11-14 IL IL15566701A patent/IL155667A0/xx unknown
- 2001-11-14 CN CNA018220282A patent/CN1486183A/zh active Pending
- 2001-11-14 SK SK742-2003A patent/SK7422003A3/sk not_active Application Discontinuation
- 2001-11-14 EP EP01985480A patent/EP1341536A4/en not_active Withdrawn
- 2001-11-14 JP JP2002542257A patent/JP2004513899A/ja active Pending
- 2001-11-14 PL PL01361875A patent/PL361875A1/xx not_active Application Discontinuation
- 2001-11-14 AU AU2002235129A patent/AU2002235129A1/en not_active Abandoned
- 2001-11-14 US US09/993,782 patent/US6528521B2/en not_active Expired - Fee Related
- 2001-11-14 HU HU0302436A patent/HUP0302436A3/hu unknown
- 2001-11-14 CZ CZ20031540A patent/CZ20031540A3/cs unknown
-
2003
- 2003-05-06 ZA ZA200303471A patent/ZA200303471B/en unknown
- 2003-05-14 NO NO20032189A patent/NO20032189L/no unknown
- 2003-06-04 BG BG107874A patent/BG107874A/bg unknown
Also Published As
Publication number | Publication date |
---|---|
JP2004513899A (ja) | 2004-05-13 |
NO20032189L (no) | 2003-07-08 |
CZ20031540A3 (cs) | 2004-05-12 |
SK7422003A3 (en) | 2004-01-08 |
HUP0302436A3 (en) | 2004-10-28 |
EP1341536A2 (en) | 2003-09-10 |
WO2002039879A3 (en) | 2002-07-25 |
KR20030077538A (ko) | 2003-10-01 |
PL361875A1 (en) | 2004-10-04 |
NO20032189D0 (no) | 2003-05-14 |
AU2002235129A1 (en) | 2002-05-27 |
ZA200303471B (en) | 2004-08-06 |
MXPA03004288A (es) | 2004-09-10 |
US6528521B2 (en) | 2003-03-04 |
HUP0302436A2 (hu) | 2003-11-28 |
CA2429047A1 (en) | 2002-05-23 |
CN1486183A (zh) | 2004-03-31 |
EP1341536A4 (en) | 2007-08-01 |
BG107874A (bg) | 2004-01-30 |
WO2002039879A2 (en) | 2002-05-23 |
IL155667A0 (en) | 2003-11-23 |
US20020115683A1 (en) | 2002-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101140510B1 (ko) | 우울증 치료용 로티고틴의 용도 | |
BR0111982A (pt) | Tratamento com apomorfina, de disfunção sexual induzida por droga anti depressão | |
Lieberman | History of the use of antidepressants in primary care | |
KR980000447A (ko) | 미르타자핀과 하나 이상의 선택적인 세로토닌 재이용 저해제로 이루어진 약학 조성물 | |
BRPI0712976A2 (pt) | uso de 2-aminotetralinas substituÍdas para a fabricaÇço de um medicamento para a prevenÇço, alÍvio e/ou tratamento de vÁrios tipos de dor | |
NO2012015I2 (no) | Dapoxetine | |
BR0316685A (pt) | Composições e métodos para a administração aperfeiçoada por via mucosal de peptìdeos fixadores ao receptor de y2 e métodos para tratar e prevenir a obesidade | |
BRPI0610509A2 (pt) | tratamento de dependência a drogas | |
EA200700214A1 (ru) | Мемантин в качестве дополнительной терапии к атипичным антипсихотическим средствам у больных шизофренией | |
BR0112661A (pt) | Nova combinação de agonista (5ht2) e antagonista (5ht6) da serotonina como formulação farmacêutica | |
BRPI0414347A (pt) | associação compreendendo um ligando de alfa-2-delta e um ssri e/ou snri para tratamento de depressão e distúrbios da ansiedade | |
Ago et al. | Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice | |
NZ575218A (en) | Use of the enantiomer (1S,2R) of milnacipran for the preparation of a medicament | |
BRPI0406749A (pt) | Métodos relacionados ao tratamento de distúrbios fincionais do intestino e composição farmacêutica | |
PT1276476E (pt) | Utilizacao de substancias bradicardicas no tratamento de doencas do miocardio associadas a hipertrofia e novas combinacoes de medicamentos | |
JP2012036212A (ja) | ムスカリン性受容体m1拮抗剤を使用する精神状態の処置 | |
JP2010530867A (ja) | うつ病の治療 | |
BR0111002A (pt) | Combinação de secretagogos do hormÈnio do crescimento e antidepressivos | |
AR029666A1 (es) | Uso del (+) -alfa-(2,3-dimetoxifenil)-1-[2-(4-fluorofenil)etil]-4-piperidinmetanol o su prodroga para la manufactura de un medicamento en el tratamiento de los sintomas de la demencia y de la psicosis inducida por dopamina | |
CL2021003312A1 (es) | Composición que comprende pridopidina y un análogo de la misma para el tratamiento de la enfermedad de huntington y síntomas de la misma. | |
AR037315A1 (es) | Uso de la apomorfina en la fabricacion de un medicamento util para la disfuncion sexual inducida por drogas antidepresivas | |
Makhija et al. | Reconsidering pimozide for new-onset delusions of parasitosis | |
UA111479U (uk) | Спосіб лікування проявів опіатного абстинентного синдрому | |
UA23887U (en) | Method for treating postabstinent state in opiate addiction | |
KR970702037A (ko) | 지발성 디스키네시아의 치료용 의약 조성물과 이의 용도 기술분야 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A , 7A E 8A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2016 DE 25/08/2009. |